Marie Didembourg

No ORCID on file · 1 paper in corpus · active 2026

Study types

  • review 1

Condition tags

  • endometriosis 1
review 2026
Journal of the Endocrine Society ·doi:10.1210/jendso/bvaf190

BACKGROUND: Relugolix, an oral GnRH receptor antagonist, is effective in treating uterine myomas and endometriosis. However, concerns persist regarding the venous thromboembolism (VTE) risk associated with its combination with oral estradio…